Irene De Gennaro Aquino
Florence, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effectiveness and safety of avelumab maintenance in patients aged ≥75 years with advanced urothelial cancer: a sub-analysis of the meet-URO 25 (MALVA) study.
Journal: Frontiers in immunology
Published: February 26, 2026
Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25.
Journal: Cancer immunology, immunotherapy : CII
Published: October 14, 2025
Overlapping Extremes: An Analysis of Avelumab Maintenance and Pembrolizumab in Advanced Urothelial Carcinoma.
Journal: Oncology and therapy
Published: August 29, 2025
Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancer.
Journal: Cancer chemotherapy and pharmacology
Published: June 09, 2025
Real-world effectiveness of Avelumab maintenance in advanced urothelial carcinoma: results from the Italian multicenter MALVA study (Meet-URO 25).
Journal: The oncologist
Published: June 06, 2025
Antibody-drug conjugates in metastatic urothelial cancer: Highway to heaven.
Journal: World journal of clinical oncology
Published: March 04, 2025
Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25).
Journal: Clinical genitourinary cancer
Published: February 28, 2024
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Journal: Cancer chemotherapy and pharmacology
Published: July 31, 2023
Correlation Between Tumor Response and Survival Outcomes in Patients with Advanced Gastric Cancer Receiving Ramucirumab and Paclitaxel as Second-Line Therapy.
Journal: Journal of gastrointestinal cancer
Published: September 11, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026